Stone L S, Kline O R, Sklar C
J Am Intraocul Implant Soc. 1985 Mar;11(2):165-8. doi: 10.1016/s0146-2776(85)80013-6.
Questionnaires were sent to 200 members of the American Intra-Ocular Implant Society to assess the preoperative, intraoperative, and postoperative management trends with intraocular lens implant patients on warfarin sodium and aspirin therapy. Responses were received from 135 members. A sizable majority of practitioners (75%) withhold warfarin sodium both prior to and following surgery. In many cases, the medicine is withheld for longer than is necessary, increasing the risk of medical complications. Respondents slightly favored (53%) discontinuing aspirin, which is perceived to be less harmful than warfarin sodium, preoperatively. Although management decisions must be individualized, according to both the surgeon's technique and the particular patient, certain general guidelines are applicable.
向美国眼内植入学会的200名成员发送了调查问卷，以评估接受华法林钠和阿司匹林治疗的人工晶状体植入患者的术前、术中和术后管理趋势。收到了135名成员的回复。绝大多数从业者（75%）在手术前后都停用华法林钠。在许多情况下，药物停用时间超过必要时长，增加了医疗并发症的风险。受访者略倾向于（53%）在术前停用阿司匹林，阿司匹林被认为比华法林钠危害小。尽管管理决策必须根据外科医生的技术和特定患者进行个体化，但某些一般准则是适用的。
